No. of patients | AUROC | 95% CI | Threshold (%)a | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
---|---|---|---|---|---|---|---|---|
Monnet et al. [8] | 34 | 0.97 | 0.85–1.00 | 5 | 91 | 100 | 100 | 84 |
Monnet et al. [18] | 39 | 0.97 | 0.91–1.00 | 5 | 100 | 91 | 90 | 100 |
Monnet et al. [11] | 54 | 0.95 | NA | 5 | 93 | 92 | 94 | 91 |
Silva et al. [19] | 34 | 0.96 | 0.82–0.99 | 6 | 100 | 90 | 86 | 100 |
Guinot et al. [12] | 42 | 0.78 | 0.63–0.89 | 2.3 | 82 | 71 | 85 | 66 |
Biais et al. [13] | 41 | 0.91 | 0.81–1.00 | 5 | 100 | 81 | 83 | 100 |
Myatra et al. [14] | 30 | 0.95 | 0.88–1.00 | 4.1 | 88 | 93 | 93 | 87 |
Yonis et al. [15] | 33 | 0.65 | 0.46–0.84 | 10 | 33 | 100 | 100 | 64 |
Jozwiak et al. [16] | 30 | 0.98 | 0.85–1.00 | 4 | 93 | 100 | 100 | 93 |
Georges et al. [17] | 50 | 0.96 | NA | 9 | 89 | 95 | 96 | 87 |
Dépret et al. [20] | 28 | 0.95 | 0.79–0.99 | 3 | 86 | 93 | 92 | 87 |
Messina et al. [21] | 40 | 0.93 | 0.84–1.00 | 3.6 | 89 | 86 | 87 | 88 |
Xu et al. [22] | 75 | 0.9 | 0.83–0.97 | 5 | 81 | 93 | 91 | 84 |